TFF2 and colitis: Here, we show that, similar to Ad-Tff2, administration of Ad-Tff2-CTP-Flag decreases tumor number in AOM/DSS- treated mice and suppresses the expansion of CD11b+Gr-1+ cells (MDSCs) in the DSS-induced colitis model.